Click on image to view larger version.

Figure 3 Efficacy in individual doses compared with placebo. Time to first symptomatic arrhythmia recurrence increased across doses as the dose changed from placebo to 50 mg QD, 100 mg QD and 125 mg QD. CHF = congestive heart failure; QD = daily.